Search for: "GENENTECH, INC."
Results 361 - 380
of 469
Sort by Relevance
|
Sort by Date
21 Apr 2009, 2:20 pm
., biotech [Biogen Idec Inc. [read post]
21 Apr 2009, 9:01 am
Raptiva’s History and Intended Use Raptiva is manufactured by Genentech, Inc. and was originally approved for distribution by the FDA in 2003. [read post]
20 Apr 2009, 10:30 pm
Genentech, Inc.), at least part of the Court's reasoning has been an attempt to prevent the Federal Circuit from developing and enforcing "bright line"... [read post]
17 Apr 2009, 5:21 pm
Genentech, Inc. made known on April 8, 2009 the phased voluntary removal of the psoriasis drug Raptiva (efalizumab) from the United States market. [read post]
17 Apr 2009, 1:57 pm
Raptiva, a drug manufactured by Roche HoldingAG's Genentech Inc. and marketed for the treatment of psoriasis has been linked to a rare but often fatal brain disorder. [read post]
9 Apr 2009, 2:16 pm
Genentech Inc. announced that at least three patients have been infected with the brain infection progressive multifocal leukoencephalopathy (PML) since October. [read post]
9 Apr 2009, 12:34 pm
Due To Link With Fatal Brain Infection, Progressive Multifocal Leukoencephalopathy (PML) (Posted by Tom Lamb at DrugInjuryWatch.com) On April 8, 2009 Genentech Inc. -- which was just acquired by Roche Holding AG in March 2009 -- issued a press release announcing "a phased voluntary withdrawal of psoriasis drug Raptiva ® (efalizumab) from the U.S. market" due to its link to a brain infection, progressive multifocal leukoencephalopathy (PML). [read post]
8 Apr 2009, 11:47 am
There will be a phased voluntary withdrawal of psoriasis drug Raptiva from the U.S. market due to its link to a brain infection.Raptiva has recently been associated with an increased risk of progressive multifocal leukoencephalopathy (PML), a rare and usually fatal disease of the central nervous system.Authorities in Europe, where Raptiva is sold by Merck KGaA (MRCG.DE), recommended in February that the drug be suspended in light of the PML risk.The European Commission is expected to follow that… [read post]
6 Apr 2009, 8:20 am
., Roche Holding AG, Bayer AG, Johnson & Johnson, Forest Laboratories Inc., Eli Lilly & Co., Boehringer Ingelheim GmbH, Genentech Inc., GlaxoSmithKline Plc and Novartis AG. [read post]
28 Mar 2009, 4:40 pm
., Craig Allen Nard, The Law of Patents 34 (2008) (asserting PTO grants patents on 39% of applications); Brief of the Boston Patent Law Ass'n as Amicus Curiae in Support of Genentech, Inc., on the Merits at 5, Medimmune, Inc. v. [read post]
5 Mar 2009, 4:54 pm
The Innovation Alliance has a fact sheet summing up the changing case law since 2006 as follows: eBay Inc. v. [read post]
3 Mar 2009, 2:43 pm
Genentech, Inc., 549 U.S. 1163 (2007); and extended the patent exhaustion doctrine in Quanta Computer, Inc. [read post]
27 Feb 2009, 5:00 am
Teva Parenteral Medicines Inc. et al. [read post]
19 Feb 2009, 2:46 pm
At the recommendation of Health Canada, EMD Serono Canada Inc. has suspended the marketing of Raptiva in Canada due to safety concerns, including the increased risk of developing PML. [read post]
30 Jan 2009, 9:58 pm
Roche Seeks Hostile Takeover of Genentech Roche has indicated that it will turn to Genentech shareholders in an attempt to complete its desired purchase of the 44% of Genentech it does not own (see N.Y. [read post]
25 Jan 2009, 2:36 pm
A Pfizer-Wyeth agreement would exceed Roche Holding AG's $43.7 billion offer for the remainder of Genentech Inc., announced in July. [read post]
6 Jan 2009, 9:14 am
Genentech case (opinion by Judge Newman) held that it would, while Atlantic Thermoplastics Co., Inc. v. [read post]
19 Dec 2008, 1:00 pm
(IP Kenya) UK: Damages for observing patent injunction: Les Laboratoires Servier & Anor v Apotex Inc & Ors (IP finance) US/China: ‘Eli Lilly lobbies on counterfeiting and regulatory issues involving China’ (IP Dragon) US: Federal judge dismisses patent lawsuit filed by Human Genome Sciences against Genentech over patent related to type of protein that can be used to detect tumours (Law360) US: MedImmune seeks invalidation of five patents owned by… [read post]
19 Dec 2008, 8:07 am
Genentech Inc., 1-08-cv-00166 (DED December 17, 2008, Memorandum Opinion) [read post]
25 Oct 2008, 12:18 am
(Class 46) New Zealand Two for one in the House: Treaties and Anti-Counterfeiting Bill (International Law Office) South Africa 'Softlifting' adds to South African piracy woes (Afro-IP) Spain 'Theory of consumer error' rejected in criminal trade mark proceedings in Spain (Class 46) Switzerland Swiss Federal Institute of Intellectual Property (IGE) reports progress in quest for improving legal protection for ‘Made in… [read post]
